Role reversal for anticancer agents

被引:9
|
作者
Pardee, AB [1 ]
机构
[1] Harvard Univ, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
cancer; chemotherapy; checkpoint; flavopiridol; paclitaxel;
D O I
10.4161/cbt.1.4.22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:426 / 427
页数:2
相关论文
共 50 条
  • [1] ROLE OF REVERSAL AGENTS
    FRAGEN, RJ
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 1992, 4 (05) : S9 - S15
  • [2] Triterpenoids as reversal agents for anticancer drug resistance treatment
    Yan, Xiao-Jian
    Gong, Li-Hua
    Zheng, Fei-Yun
    Cheng, Ke-Jun
    Chen, Zhe-Sheng
    Shi, Zhi
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (04) : 482 - 488
  • [3] Role of Heteroaromatics as Anticancer Agents
    Kaur, Harmeet
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (10) : 1204 - 1204
  • [4] Role of BAX in the apoptotic response to anticancer agents
    Zhang, L
    Yu, J
    Park, BH
    Kinzler, KW
    Vogelstein, B
    [J]. SCIENCE, 2000, 290 (5493) : 989 - +
  • [5] The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
    Andradas, Clara
    Truong, Alexandra
    Byrne, Jacob
    Endersby, Raelene
    [J]. CANCERS, 2021, 13 (01) : 1 - 14
  • [6] New Anticancer Agents: Role of Clinical Pharmacy Services
    Leveque, Dominique
    Delpeuch, Amina
    Gourieux, Benedicte
    [J]. ANTICANCER RESEARCH, 2014, 34 (04) : 1573 - 1578
  • [7] The role of the proteasome in apoptosis induced by anthracycline anticancer agents
    Kiyomiya, KI
    Kurebe, M
    Nakagawa, H
    Matsuo, S
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (06) : 1205 - 1209
  • [8] Translational role of natural coumarins and their derivatives as anticancer agents
    Menezes, Jose C. J. M. D. S.
    Diederich, Marc
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 1057 - 1082
  • [9] ANTICANCER AGENTS
    NEWELL, FW
    [J]. INVESTIGATIVE OPHTHALMOLOGY, 1964, 3 (05): : 489 - 491
  • [10] New role for an established drug? Bisphosphonates as potential anticancer agents
    H K Koul
    S Koul
    R B Meacham
    [J]. Prostate Cancer and Prostatic Diseases, 2012, 15 : 111 - 119